DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 132 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $66,000 | -59.3% | 17,036 | +9.7% | 0.00% | – |
| Q3 2016 | $162,000 | -33.3% | 15,534 | -6.9% | 0.00% | – |
| Q2 2016 | $243,000 | -25.2% | 16,677 | -1.3% | 0.00% | – |
| Q1 2016 | $325,000 | -17.5% | 16,893 | +3.8% | 0.00% | – |
| Q4 2015 | $394,000 | +22.4% | 16,282 | +24.3% | 0.00% | – |
| Q3 2015 | $322,000 | +65.1% | 13,099 | +56.9% | 0.00% | – |
| Q2 2015 | $195,000 | +22.6% | 8,347 | +17.6% | 0.00% | – |
| Q1 2015 | $159,000 | +152.4% | 7,097 | +91.0% | 0.00% | – |
| Q4 2014 | $63,000 | – | 3,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |